Expression of CD31, Met/hepatocyte growth factor receptor and bone morphogenetic protein in bone metastasis of osteosarcoma

Citation
K. Arihiro et K. Inai, Expression of CD31, Met/hepatocyte growth factor receptor and bone morphogenetic protein in bone metastasis of osteosarcoma, PATHOL INT, 51(2), 2001, pp. 100-106
Citations number
45
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
PATHOLOGY INTERNATIONAL
ISSN journal
13205463 → ACNP
Volume
51
Issue
2
Year of publication
2001
Pages
100 - 106
Database
ISI
SICI code
1320-5463(200102)51:2<100:EOCMGF>2.0.ZU;2-H
Abstract
The mechanism of metastasis of osteosarcoma cells to other bones has not ye t fully been clarified. The purpose of the present study was to examine whe ther various factors involve the formation of osteosarcoma metastatic foci in other bones. Immunohistochemically, CD31 expression in osteosarcoma with no bone metastasis and osteosarcoma with bone metastasis was noted in 10 a nd 75% of cases, respectively. Met/hepatocyte growth factor (HGF) receptor expression in osteosarcoma with no bone metastasis and osteosarcoma with bo ne metastasis was noted in 90 and 25% of cases, respectively. Bone morphoge netic protein (BMP) expression in osteosarcoma with no bone metastasis and osteosarcoma with bone metastasis was noted in 20 and 75% of cases, respect ively. Metastasis of osteosar-coma cells to other bones was significantly c orrelated with expression of BMP and CD31 and with no expression of Met/HGF receptor protein in osteosarcoma cells. In contrast, expression of insulin -like growth factor receptor in osteosarcoma cells did not correlate signif icantly with bone metastasis. These results suggest that formation of metas tatic foci of osteosarcoma cells in other bones is regulated by CD31, which is associated with migration between endothelial cells, by BMP, which can induce and activate various mesenchymal cells affecting bone formation, and by escape of effect by HGF, which promotes differentiation of osteosarcoma cells.